A61K 38/28
Insulins
A61K38/28 (Insulins) appears on 2,093 US grants and 3,514 published applications in this corpus.
Search patents in A61K- Granted patents
- 2,093
- Published applications
- 3,514
- Assignees
- 1,152
- Inventors
- 4,769
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 1 | 0 |
| 1978 | 1 | 0 |
| 1979 | 4 | 0 |
| 1980 | 1 | 0 |
| 1981 | 0 | 0 |
| 1982 | 1 | 0 |
| 1983 | 2 | 0 |
| 1984 | 3 | 0 |
| 1985 | 3 | 0 |
| 1986 | 5 | 0 |
| 1987 | 5 | 0 |
| 1988 | 2 | 0 |
| 1989 | 6 | 0 |
| 1990 | 4 | 0 |
| 1991 | 3 | 0 |
| 1992 | 9 | 0 |
| 1993 | 9 | 0 |
| 1994 | 12 | 0 |
| 1995 | 20 | 0 |
| 1996 | 8 | 0 |
| 1997 | 32 | 0 |
| 1998 | 38 | 0 |
| 1999 | 43 | 0 |
| 2000 | 29 | 0 |
| 2001 | 40 | 28 |
| 2002 | 45 | 64 |
| 2003 | 45 | 98 |
| 2004 | 25 | 82 |
| 2005 | 27 | 91 |
| 2006 | 45 | 112 |
| 2007 | 30 | 115 |
| 2008 | 35 | 114 |
| 2009 | 30 | 110 |
| 2010 | 59 | 126 |
| 2011 | 48 | 140 |
| 2012 | 67 | 124 |
| 2013 | 76 | 147 |
| 2014 | 103 | 176 |
| 2015 | 117 | 211 |
| 2016 | 116 | 211 |
| 2017 | 115 | 165 |
| 2018 | 108 | 176 |
| 2019 | 106 | 197 |
| 2020 | 112 | 196 |
| 2021 | 128 | 175 |
| 2022 | 80 | 155 |
| 2023 | 91 | 146 |
| 2024 | 82 | 148 |
| 2025 | 77 | 111 |
| 2026 | 44 | 96 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Dynamic-covalent hydrogels with glucose-specific and glucose-responsive diboronate crosslinking29 Sep 2026US 12,746,277 B2University of Notre Dame du Lac
- Apparatus, system and method for detecting and monitoring inhalations8 Sep 2026US 12,728,216 B2MannKind Corporation
- Polyphenolic insulin18 Aug 2026US 12,708,659 B2Kimball Westward LLC
- Conjugates for selective responsiveness to vicinal diols18 Aug 2026US 12,709,622 B2Protomer Technologies, Inc.
- Long-acting GLP-1 compound11 Aug 2026US 12,703,731 B2Gan & Lee Pharmaceuticals
- Compositions and methods for propogating insulin and glucagon secreting cells from type 1 diabetic pancreatic tissue and therapeutic uses thereof8 Oct 2026US 2026/0308529 A1Imagine Pharma LLC
- Diffusion resistance layer for analyte sensors8 Oct 2026US 2026/0309670 A1DexCom, Inc.
- Water-soluble biomolecular glass microneedle and preparation method thereof1 Oct 2026US 2026/0294794 A1Institute of Process Engineering, Chinese Academy of Sciences
- Antidiabetic pharmaceutical composition1 Oct 2026US 2026/0294823 A1Imam Abdulrahman Bin Faisal University
- Aptamer-based sustained release of therapeutic agents1 Oct 2026US 2026/0294954 A1Children's Medical Center Corporation
Most cited
By later US patents
- System and method for initiating and maintaining continuous, long-term control of a concentration of a substance in a patient using a feedback or model-based controller coupled to a single-needle or multi-needle intradermal (ID) delivery device968US 7,060,059 B2Becton, Dickinson and Company · 2006
- Preparation of particles for inhalation553US 5,985,309 AMassachusetts Institute of Technology · 1999
- Particles incorporating surfactants for pulmonary drug delivery537US 5,855,913 AMassachusetts Instite of Technology · 1999
- Method and apparatus for glucose control and insulin dosing for diabetics455US 7,651,845 B2The Regents of the University of California · 2010
- Engineered nucleic acids and methods of use thereof372US 8,822,663 B2Moderna Therapeutics, Inc. · 2014